Summary of the latest safety advice for medicines and medical device users
Similar Posts
RegulatoryConnect
The Medicines and Healthcare Regulatory Agency have launched RegulatoryConnect, a service that provides the capability to track applications and view live authorisation details.
Strengthening collaboration between the MHRA and the Department of Health Northern Ireland
The MHRA and Northern Ireland partners are working together to support innovation, enhance patient safety and ensure people in Northern Ireland benefit from world-class regulation.
Submission and assessment timetables for innovative medicines applications
Guidance on the deadlines for initial and response submissions.
MHRA and NICE receive £2 million from Wellcome to improve safety and effectiveness of digital mental health technologies
Additional funding will allow the MHRA and NICE to continue developing clear, proportionate guidance for digital mental health technologies, supporting safer, more effective tools for people across the UK.
Mirvetuximab soravtansine approved to treat adult patients who have ovarian, fallopian tube or primary peritoneal cancer
The approval is supported by a study involving 453 adults with advanced platinum-resistant cancers of the ovary, fallopian tubes and the peritoneum that were FRα positive
Guidance: Field safety notice (FSN): what it is and why it’s important
A flyer to circulate to customers alongside a field safety notice covering what it is and why it’s important to take action.